Cargando…

Disease severity and proton pump inhibitor use impact strongest on faecal microbiome composition in liver cirrhosis

BACKGROUND & AIMS: Compositional changes of the faecal microbiome in cirrhosis are well described and have been associated with complications and prognosis. However, it is less well known, which disease or treatment‐related factors affect microbiome composition most distinctively. METHODS: 16S r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stadlbauer, Vanessa, Komarova, Irina, Klymiuk, Ingeborg, Durdevic, Marija, Reisinger, Alexander, Blesl, Andreas, Rainer, Florian, Horvath, Angela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Gut‐liver Axis, Immunology, Immune Mediated and Cholestatic Diseases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187411/ https://www.ncbi.nlm.nih.gov/pubmed/31943691 http://dx.doi.org/10.1111/liv.14382

Ejemplares similares

A novel non‐bile acid FXR agonist EDP‐305 potently suppresses liver injury and fibrosis without worsening of ductular reaction
por: An, Ping, et al.
Publicado: (2020)

Reduction and stabilization of bilirubin with obeticholic acid treatment in patients with primary biliary cholangitis
por: Parés, Albert, et al.
Publicado: (2020)

High discontinuation rate of azathioprine in autoimmune hepatitis, independent of time of treatment initiation
por: Pape, Simon, et al.
Publicado: (2020)

The Simple Cholestatic Complaints Score is a valid and quick patient‐reported outcome measure in primary sclerosing cholangitis
por: van Munster, Kim N., et al.
Publicado: (2020)

Environmental risk factors are associated with autoimmune hepatitis
por: Lammert, Craig, et al.
Publicado: (2021)

Combination antiretroviral therapy improves recurrent primary biliary cholangitis following liver transplantation
por: Lytvyak, Ellina, et al.
Publicado: (2021)

A novel serum metabolomic panel distinguishes IgG4‐related sclerosing cholangitis from primary sclerosing cholangitis
por: Radford‐Smith, Daniel E., et al.
Publicado: (2022)

Symptom patterns in the daily life of PSC patients
por: van Munster, Kim N., et al.
Publicado: (2022)

Predictors of serious adverse events and non‐response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid
por: De Vincentis, Antonio, et al.
Publicado: (2022)

Extrahepatic autoimmune diseases in autoimmune hepatitis: Effect on mortality
por: Birn‐Rydder, Rasmine, et al.
Publicado: (2022)

Confidence in treatment is contributing to quality of life in autoimmune liver diseases. The results of ERN RARE‐LIVER online survey
por: Wunsch, Ewa, et al.
Publicado: (2022)

High prevalence of lower limb atherosclerosis is linked with the gut–liver axis in patients with primary biliary cholangitis
por: Ponziani, Francesca Romana, et al.
Publicado: (2022)

Impact on follow‐up strategies in patients with primary sclerosing cholangitis
por: Bergquist, Annika, et al.
Publicado: (2022)

Portal pressure is of significant prognostic value in primary biliary cholangitis
por: Warnes, Thomas W., et al.
Publicado: (2022)

Bile acids increase steroidogenesis in cholemic mice and induce cortisol secretion in adrenocortical H295R cells via S1PR2, ERK and SF‐1
por: Liu, Lei, et al.
Publicado: (2019)

Compartment-specific immunity in the human gut: properties and functions of dendritic cells in the colon versus the ileum
por: Mann, Elizabeth R, et al.
Publicado: (2016)

Biomarkers for oralization during long-term proton pump inhibitor therapy predict survival in cirrhosis
por: Horvath, Angela, et al.
Publicado: (2019)

A single alcohol binge impacts on neutrophil function without changes in gut barrier function and gut microbiome composition in healthy volunteers
por: Stadlbauer, Vanessa, et al.
Publicado: (2019)

Utility of fluorescence imitating brightfield imaging microscopy for the diagnosis of feline chronic enteropathy
por: Au Yeung, Sarah, et al.
Publicado: (2022)

The renin‐angiotensin‐aldosterone system, neurohumoral axis and cardiovascular mortality in LURIC
por: Yazdani, Babak, et al.
Publicado: (2022)

Increased expression of the urokinase plasminogen activator system by Helicobacter pylori in gastric epithelial cells
por: Kenny, Susan, et al.
Publicado: (2008)

EP(2) and EP(4) receptors on muscularis resident macrophages mediate LPS-induced intestinal dysmotility via iNOS upregulation through cAMP/ERK signals
por: Tajima, Tsuyoshi, et al.
Publicado: (2012)

Intestinal epithelial suppressor of cytokine signaling 3 enhances microbial-induced inflammatory tumor necrosis factor-α, contributing to epithelial barrier dysfunction
por: Thagia, Imtiyaz, et al.
Publicado: (2014)

Faecal microbiota transplantation: applications and limitations in treating gastrointestinal disorders
por: Sbahi, Hani, et al.
Publicado: (2016)

A novel faecal Lachnoclostridium marker for the non-invasive diagnosis of colorectal adenoma and cancer
por: Liang, Jessie Qiaoyi, et al.
Publicado: (2020)

Bacteriophage transfer during faecal microbiota transplantation in Clostridium difficile infection is associated with treatment outcome
por: Zuo, Tao, et al.
Publicado: (2018)

Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection
por: Mullish, Benjamin H, et al.
Publicado: (2019)

Proton pump inhibitors affect the gut microbiome
por: Imhann, Floris, et al.
Publicado: (2016)

Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study
por: El-Salhy, Magdy, et al.
Publicado: (2020)

Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial
por: de Groot, Pieter, et al.
Publicado: (2021)

Effective treatment of canine chronic cutaneous lupus erythematosus variants with oclacitinib: Seven cases
por: Harvey, Richard G., et al.
Publicado: (2022)

The effects of a multispecies synbiotic on microbiome-related side effects of long-term proton pump inhibitor use: A pilot study
por: Horvath, Angela, et al.
Publicado: (2020)

IL‐31 levels correlate with pruritus in patients with cholestatic and metabolic liver diseases and is farnesoid X receptor responsive in NASH
por: Xu, Jun, et al.
Publicado: (2023)

A shared mucosal gut microbiota signature in primary sclerosing cholangitis before and after liver transplantation
por: Hole, Mikal Jacob, et al.
Publicado: (2023)

CD8(+) T cell memory is sustained in mice by hepatic stellate cells
por: Chen, Yi‐Ting, et al.
Publicado: (2023)

Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time
por: de Groot, Pieter, et al.
Publicado: (2020)

Integrated analysis of the faecal metagenome and serum metabolome reveals the role of gut microbiome-associated metabolites in the detection of colorectal cancer and adenoma
por: Chen, Feng, et al.
Publicado: (2022)

Proton pump inhibitors alter the composition of the gut microbiota
por: Jackson, Matthew A, et al.
Publicado: (2016)

Scientific frontiers in faecal microbiota transplantation: joint document of Asia-Pacific Association of Gastroenterology (APAGE) and Asia-Pacific Society for Digestive Endoscopy (APSDE)
por: Ng, Siew C, et al.
Publicado: (2020)

Acute kidney injury is independently associated with death in patients with cirrhosis
por: Scott, Robert A, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ri1bf0kk58f0b5r8e24aeegkte